Related Experiment Video

Updated: Aug 11, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum

G Fritsche1, C Larcher, H Schennach

  • 1Department of Internal Medicine, University Hospital, Anichstr. 35, A-6020 Innsbruck, Austria.

The Journal of Infectious Diseases
|April 11, 2001
PubMed

Insights

Iron chelation therapy for cerebral malaria enhances nitric oxide (NO) production, which kills malaria parasites. This NO-mediated killing, not iron reduction, is key to the therapy

Area of Science:

  • Immunology
  • Infectious Diseases
  • Parasitology

Background:

  • Cerebral malaria, a severe complication of Plasmodium falciparum infection, impacts children globally.
  • Iron chelation therapy, using agents like desferrioxamine (DFO), shows promise in alleviating cerebral malaria.
  • The precise mechanisms by which DFO exerts its therapeutic effects remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the efficacy of iron chelation therapy in Plasmodium falciparum infection.
  • To investigate the role of nitric oxide (NO) and other inflammatory mediators in DFO's anti-malarial effects.

Main Methods:

  • Utilized human intestinal cell line (DLD-1) and murine macrophage cell line (RAW 264.7) stimulated with cytokines.
  • Co-cultured stimulated cells with human erythrocytes infected with Plasmodium falciparum.
  • Assessed nitric oxide (NO) production, parasite survival, and the impact of DFO and NO inhibition (L-N6-(1-iminoethyl)-lysine).

Main Results:

  • Cytokine stimulation increased nitric oxide (NO) production and reduced Plasmodium falciparum survival.
  • Desferrioxamine (DFO) pre-treatment amplified NO generation and parasite killing, effects dependent on NO formation.
  • Peroxynitrite, a product of NO and superoxide, identified as a key mediator of macrophage-induced parasite cytotoxicity, with interferon-gamma as a major regulatory cytokine.

Conclusions:

  • The therapeutic effect of DFO in Plasmodium falciparum infection is primarily mediated by enhanced nitric oxide (NO) generation.
  • Peroxynitrite is the principal effector molecule in macrophage-driven parasite clearance.
  • DFO's efficacy stems from boosting NO-mediated pathways rather than direct iron limitation for the parasite.

More Related Videos

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells08:32

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Published on: March 16, 2017

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation07:13

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation

Published on: January 7, 2019

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...